The concept of vaccines can never escape the "day trip"

Author: Cephalosporin

There have been several daylight scenes since the first exposure of "Omi Keron" in the world.

According to relevant reports, 11 countries and regions around the world have reported Omicron.

As for the market, from the first outbreak of the new crown, from primitive to delta, and finally to the Omi Keron virus this time, the virus comes and goes, but the concept of the global stock market has ups and downs like a roller coaster, plus a lot of Research institutions believe that "Omi Keron" will boost the "new crown concept stocks" to a certain extent, causing many investors to mistakenly believe that the initial market for the new crown concept seems to be breaking out again?

However, as far as the current market performance is concerned, at least domestic related concepts have not reached the "expectation" of the public

Facing the ravages of Omicron, domestic related companies have successively carried out the evaluation and research work of Omicron strains, and the manufacturers of related testing reagents have also continuously emphasized the product’s ability to detect Omicron

In foreign countries, after the vaccine giant Moderna soared by 20% last week, the market closed up 11.

Domestically, in the field of testing reagents, "Zhijiang Bio", after rising by 12.

Compared with testing reagents, the situation in the vaccine industry is even more miserable.

On the 29th, the market opened low and moved high and showed strong momentum.

In view of this situation, it really responds to the words of the majority of investors.

On the other hand, as the person in charge of Wantai Biotech said, “The most critical task at present is to assess the infectivity and hazard of Omi Keron, followed by the design and production of new vaccines.

Moreover, after the previous "pits", the current "new crown" investors are no longer the same as before.